Airway Pressure Release Ventilation (APRV) Ventilator Mode

Airway pressure release ventilation (APRV) is an advanced mode of mechanical ventilation designed to improve oxygenation while allowing for spontaneous breathing. Commonly used in patients with acute respiratory distress syndrome (ARDS) and other forms of hypoxemic respiratory failure, APRV offers a unique approach by maintaining continuous positive airway pressure with brief, intermittent releases to aid in carbon dioxide removal.

This mode combines the benefits of alveolar recruitment with the advantages of patient-initiated breathing, promoting lung protection and improved gas exchange. In this article, we’ll explore how APRV works, its key settings, clinical applications, and important considerations for safe and effective use.

Free Access

Mechanical Ventilation (Free Course)

Take our free course to master the basics of mechanical ventilation with clear explanations and helpful practice questions.

Get Free Access

What is Airway Pressure Release Ventilation (APRV)?

Airway pressure release ventilation (APRV) is a mode of mechanical ventilation that maintains continuous positive airway pressure (CPAP) at a high level (P-high) for a prolonged period to keep the lungs open, with brief, intermittent drops to a lower pressure (P-low) to allow for carbon dioxide removal.

APRV allows spontaneous breathing throughout both pressure phases, which can improve oxygenation, reduce the need for deep sedation, and help protect the lungs from injury. It is commonly used in patients with acute respiratory distress syndrome (ARDS) and other forms of severe hypoxemic respiratory failure.

How APRV Works

APRV operates on the principle of maintaining the lungs in an open and recruited state for the majority of the respiratory cycle. Unlike traditional modes that rely on fixed tidal volumes and mandatory breaths, APRV uses two levels of continuous positive airway pressure (CPAP): a high pressure (P-high) and a low pressure (P-low).

The ventilator cycles between these two pressure levels based on time settings—T-high (time at high pressure) and T-low (time at low pressure).

During the T-high phase, the lungs remain inflated, maximizing alveolar recruitment and improving oxygenation. Spontaneous breathing is encouraged throughout this phase, which can improve patient comfort and reduce the need for deep sedation or paralysis. The T-low phase is short and allows for a brief release in airway pressure, facilitating the elimination of carbon dioxide.

Note: By maintaining lung inflation and limiting the number of pressure transitions, APRV can reduce ventilator-induced lung injury (VILI) compared to conventional ventilation strategies. It is especially beneficial in conditions where alveolar collapse and poor oxygenation are significant concerns, such as ARDS.

Key Settings and Parameters in APRV

Effective use of APRV requires a solid understanding of its four primary settings: P-high, P-low, T-high, and T-low. These parameters control the timing and pressure transitions that define this unique mode of ventilation.

• P-high (High Pressure): This is the upper CPAP level where the lungs remain inflated for most of the respiratory cycle. It’s typically set near the mean airway pressure of conventional pressure-controlled ventilation and should be high enough to promote alveolar recruitment and oxygenation, usually around 20–30 cmH₂O.

• P-low (Low Pressure): This is the lower pressure to which the ventilator “releases” during T-low. In many cases, P-low is set to 0 cmH₂O to maximize expiratory flow and carbon dioxide removal. However, it can be adjusted slightly above 0 if needed for patient comfort or hemodynamic stability.

• T-high (Time at High Pressure): T-high determines how long the lungs stay at the high pressure level. It’s typically set between 4 to 6 seconds, allowing for optimal alveolar recruitment and gas exchange. This phase occupies the majority of the ventilatory cycle.

• T-low (Time at Low Pressure): T-low is usually very short—0.2 to 0.8 seconds—and controls how long the pressure is released to P-low. This brief interval helps eliminate CO₂ while preventing complete alveolar collapse by taking advantage of auto-PEEP (intrinsic PEEP).

Note: In addition to these core settings, many ventilators offer optional features such as spontaneous breath triggering, pressure support during T-high, and flow termination criteria during T-low to further fine-tune ventilation and improve patient-ventilator synchrony.

Clinical Indications for APRV

APRV is most commonly indicated for patients with acute hypoxemic respiratory failure, especially those diagnosed with acute respiratory distress syndrome (ARDS). It is designed to maximize oxygenation by promoting alveolar recruitment while still allowing spontaneous breathing, which can reduce the need for heavy sedation and neuromuscular blockade.

Here are the most common clinical scenarios where APRV may be considered:

• ARDS and refractory hypoxemia: APRV has shown potential in improving oxygenation in patients with moderate to severe ARDS by sustaining lung recruitment and reducing cyclic alveolar collapse.

• Lung-protective ventilation strategies: Because APRV minimizes large pressure swings and encourages spontaneous breathing, it may reduce the risk of ventilator-induced lung injury (VILI) and barotrauma.

• Postoperative respiratory failure: In some surgical patients who develop atelectasis or respiratory compromise, APRV may aid in alveolar recruitment and help avoid intubation escalation.

• Patients difficult to sedate or paralyze: APRV supports spontaneous ventilation, which is beneficial for patients who are awake, agitated, or difficult to sedate deeply.

• Pediatric and trauma patients: Select studies have explored APRV in children and trauma patients with promising results, though further research is ongoing.

Note: APRV should be used by clinicians who are trained in its setup and interpretation, as its success depends heavily on proper parameter adjustment and patient selection.

Advantages of APRV

Airway Pressure Release Ventilation offers several unique benefits compared to traditional mechanical ventilation modes, particularly in patients with severe hypoxemia or lung injury. These advantages contribute to improved oxygenation, enhanced patient comfort, and potentially better clinical outcomes.

Here are some of the key benefits of APRV:

• Improved Oxygenation: By maintaining sustained high airway pressure (P-high) and promoting alveolar recruitment, APRV enhances oxygen exchange, even in patients with collapsed or injured lung tissue.

• Allows Spontaneous Breathing: One of APRV’s most important features is its support for spontaneous breathing throughout the entire respiratory cycle. This helps maintain diaphragm function, improve ventilation-perfusion matching, and may reduce the need for deep sedation or paralysis.

• Lung Protection: APRV uses lower tidal volumes and minimizes the repetitive opening and closing of alveoli, reducing the risk of ventilator-induced lung injury (VILI) and barotrauma.

• Better Hemodynamic Stability: Compared to conventional modes with high tidal volumes and high respiratory rates, APRV’s prolonged T-high may lead to more stable intrathoracic pressures and better cardiac output.

• Facilitates CO₂ Removal: The brief release to P-low during T-low creates a controlled method of CO₂ clearance without compromising alveolar stability.

• Reduced Sedation Requirements: Since patients can breathe spontaneously and remain more synchronized with the ventilator, APRV may lower the need for continuous sedative or neuromuscular blockade infusions.

Note: These benefits make APRV a valuable tool in managing complex respiratory conditions, especially when traditional ventilation methods are failing or poorly tolerated.

Limitations and Challenges of APRV

While APRV offers several clinical benefits, it also comes with certain limitations and challenges that must be carefully considered. Improper setup or mismanagement of APRV can lead to complications, making clinician expertise essential when using this mode.

Here are some of the key challenges and drawbacks:

• Steep Learning Curve: APRV settings differ significantly from conventional modes, and improper adjustment of P-high, P-low, T-high, and T-low can result in inadequate ventilation or alveolar collapse. Clinicians unfamiliar with APRV may find it complex to implement effectively.

• Risk of Air Trapping and Hypercapnia: If T-low is set too short, CO₂ clearance may be insufficient, potentially leading to hypercapnia. Conversely, if T-low is too long, it can cause alveolar derecruitment.

• Limited Standardization: Unlike conventional volume or pressure control modes, APRV lacks universally accepted protocols, leading to variations in practice and outcomes across institutions.

• Monitoring Difficulties: Measuring tidal volumes and tracking minute ventilation can be more challenging with APRV due to spontaneous breathing and variable flow patterns.

• Not Ideal for All Patients: APRV may not be suitable for patients with obstructive lung diseases like COPD or asthma, where air trapping and dynamic hyperinflation are concerns. It’s also not recommended for patients requiring strict control over PaCO₂ levels (e.g., in neurosurgical cases).

• Increased Work of Breathing: In some patients, spontaneous breathing efforts against high airway pressures may increase work of breathing if pressure support isn’t provided during T-high.

Note: Despite these challenges, APRV can be a highly effective ventilation strategy when used by experienced clinicians who understand how to fine-tune the mode to meet individual patient needs.

FAQs About Airway Pressure Release Ventilation (APRV)

Is APRV the Right Mode of Ventilation for ARDS Patients?

Airway Pressure Release Ventilation (APRV) can be an effective option for patients with ARDS, especially those with moderate to severe hypoxemia. It promotes alveolar recruitment, allows spontaneous breathing, and may reduce the need for deep sedation or paralysis.

However, its effectiveness depends on proper settings and clinician experience. While APRV has shown benefits in improving oxygenation and reducing ventilator-induced lung injury, it should be tailored to the individual patient and used with careful monitoring.

What Is the Difference Between Airway Pressure Release Ventilation and BiPAP?

APRV and BiPAP both involve two pressure levels, but they serve different purposes and patient populations. BiPAP is a non-invasive form of ventilation typically used for patients who are awake and breathing spontaneously, such as those with COPD exacerbations or sleep apnea.

APRV, on the other hand, is an invasive mechanical ventilation mode used in critically ill, intubated patients. It maintains high airway pressure for longer periods with brief releases, supporting oxygenation and spontaneous breathing in ARDS.

What Is Another Name for APRV?

Another commonly used name for APRV is Bilevel Ventilation, also known as BiLevel Positive Airway Pressure Ventilation—not to be confused with noninvasive BiPAP. These terms are often used interchangeably, particularly depending on the ventilator manufacturer.

For example, some ventilators label this mode as BiLevel, but the settings and principles are essentially the same as APRV: two pressure levels, a time-based cycle, and support for spontaneous breathing throughout the entire respiratory cycle.

What Sets Airway Pressure Release Ventilation (APRV) Apart From Other Ventilation Modes?

APRV differs from traditional modes by allowing spontaneous breathing at all phases of the respiratory cycle while keeping the lungs open for extended periods using sustained high pressure. It uses time-cycled transitions between two pressure levels (P-high and P-low), rather than fixed tidal volumes.

This approach supports oxygenation, promotes lung protection, and may reduce the risk of ventilator-induced lung injury. Its unique design makes it especially useful in patients with ARDS and refractory hypoxemia.

Should Airway Pressure Release Ventilation Be the Primary Mode in ARDS?

APRV can be considered as a primary mode of ventilation in ARDS, particularly for patients with severe oxygenation issues who may benefit from enhanced alveolar recruitment and spontaneous breathing.

Some studies suggest APRV may improve oxygenation and reduce ventilator-induced lung injury. However, more large-scale research is needed to confirm its superiority. Ultimately, the choice should be based on clinician expertise, patient condition, and institutional protocols. APRV is a valuable tool, but not universally appropriate for every ARDS case.

Final Thoughts

Airway pressure release ventilation (APRV) is a powerful and flexible mode of mechanical ventilation that offers distinct advantages in the management of patients with acute respiratory failure, especially those with ARDS or refractory hypoxemia.

By maintaining alveolar recruitment, supporting spontaneous breathing, and minimizing ventilator-induced lung injury, APRV can play a critical role in lung-protective strategies. However, its success depends on proper patient selection, precise ventilator settings, and a thorough understanding of its unique principles.

While not suitable for every clinical scenario, APRV is a valuable tool in the hands of trained healthcare providers looking to optimize oxygenation and reduce sedation needs. With continued research and clinical experience, APRV may become an even more widely adopted option in modern critical care practice.